<DOC>
	<DOCNO>NCT00808366</DOCNO>
	<brief_summary>The purpose study evaluate efficacy RV4104A ointment versus bifonazole-urea ointment complete removal clinically infected nail plate area patient toenail onychomycosis .</brief_summary>
	<brief_title>Efficacy Safety RV4104A Ointment Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Bifonazole</mesh_term>
	<mesh_term>Keratolytic Agents</mesh_term>
	<criteria>Clinical diagnosis distallateral lateral subungual onychomycosis one great toenail ( target nail ) Target nail plate show â‰¥ 12.5 % clinically infected area Patient must least 2 mm proximal end target nail free infection Target nail infection due exclusively dermatophyte ( positive direct microscopy examination positive fungal culture report central mycological laboratory ) Patient 2 affected toenail Patient psoriasis , lichen planus abnormality could result clinically abnormal toenail ( ) Patient moccasintype tinea pedis Patient receive systemic antifungal therapy topical antifungal nail lacquer within 3 month topical antifungal therapy apply foot toenail within 2 month prior screen visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
</DOC>